Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
|
1 |
Ackermann L. |
Mast Cell Mediators in Allergic and Chronic Skin Inflammation.
|
|
2 |
Ackermann L, Harvima IT. |
Mast cells of psoriatic and atopic dermatitis skin are positive for TNF-alpha and their degranulation is associated with expression of ICAM-1 in the epidermis.
|
|
3 |
Ackermann L et al. |
Staphylococcal enterotoxin B inhibits the production of interleukin-4 in a human mast-cell line HMC-1.
|
|
4 |
Alanko K, Kauppinen K. |
Diagnosis of drug eruptions: Clinical evaluation and drug challenge.
|
|
5 |
Hannuksela M et al. |
Drugs causing cutaneous reactions.
|
|
6 |
Harvima I. |
Diabeetikon jalkahaavaumien uudet aktiivisemmat hoitomuodot.
|
|
7 |
Kauppinen K. |
Introduction.
|
|
8 |
Kauppinen K. |
General aspects of treatment.
|
|
9 |
Kauppinen K et al., ed. |
Skin Reactions to Drugs.
|
|
10 |
Kauppinen K, Kariniemi A-L. |
Clinical manifestations and histological characteristics.
|
|
11 |
Lehmuskallio E et al. |
Paikalliskortikosteroidit ja perusvoiteet. Valinta ja käyttö ihotaudeissa.
|
|
12 |
Nordman H et al. |
Allerginen kansa -allergia kansanterveysongelmana. Konsensuslausuma.
|